Trinity Biotech (TRIB) Inventory (2009 - 2025)

Trinity Biotech has disclosed Inventory across 17 years of filings, most recently posting $18.8 million for Q4 2025.

• Inventory for Q4 2025 came in at $18.8 million, down 2.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $18.8 million (down 2.82% YoY), and the FY2025 annual result was $18.8 million, down 2.82% from the prior year.
• Inventory came in at $18.8 million for Q4 2025 at Trinity Biotech, down from $20.1 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $37.6 million in Q1 2021 to a low of $1.2 million in Q4 2023.
• The 5-year median for Inventory is $22.6 million (2023), against an average of $23.9 million.
• Across the five-year window, Inventory slumped 94.85% in 2023 and jumped 1570.17% in 2024, its largest moves.
• Trinity Biotech's Inventory stood at $29.1 million in 2021, then dropped by 22.73% to $22.5 million in 2022, then plunged by 94.85% to $1.2 million in 2023, then surged by 1570.17% to $19.4 million in 2024, then dropped by 2.82% to $18.8 million in 2025.
• The last three Inventory figures came in at $18.8 million (Q4 2025), $20.1 million (Q2 2025), and $19.4 million (Q4 2024), per Business Quant data.